220 related articles for article (PubMed ID: 18769129)
1. Cytoplasmic accumulation of the RNA binding protein HuR is central to tamoxifen resistance in estrogen receptor positive breast cancer cells.
Hostetter C; Licata LA; Witkiewicz A; Costantino CL; Yeo CJ; Brody JR; Keen JC
Cancer Biol Ther; 2008 Sep; 7(9):1496-506. PubMed ID: 18769129
[TBL] [Abstract][Full Text] [Related]
2. Post-transcriptional regulation of ERBB2 by miR26a/b and HuR confers resistance to tamoxifen in estrogen receptor-positive breast cancer cells.
Tan S; Ding K; Chong QY; Zhao J; Liu Y; Shao Y; Zhang Y; Yu Q; Xiong Z; Zhang W; Zhang M; Li G; Li X; Kong X; Ahmad A; Wu Z; Wu Q; Zhao X; Lobie PE; Zhu T
J Biol Chem; 2017 Aug; 292(33):13551-13564. PubMed ID: 28637868
[TBL] [Abstract][Full Text] [Related]
3. The RNA binding protein HuR differentially regulates unique subsets of mRNAs in estrogen receptor negative and estrogen receptor positive breast cancer.
Calaluce R; Gubin MM; Davis JW; Magee JD; Chen J; Kuwano Y; Gorospe M; Atasoy U
BMC Cancer; 2010 Apr; 10():126. PubMed ID: 20370918
[TBL] [Abstract][Full Text] [Related]
4. pp32 (ANP32A) expression inhibits pancreatic cancer cell growth and induces gemcitabine resistance by disrupting HuR binding to mRNAs.
Williams TK; Costantino CL; Bildzukewicz NA; Richards NG; Rittenhouse DW; Einstein L; Cozzitorto JA; Keen JC; Dasgupta A; Gorospe M; Gonye GE; Yeo CJ; Witkiewicz AK; Brody JR
PLoS One; 2010 Nov; 5(11):e15455. PubMed ID: 21152064
[TBL] [Abstract][Full Text] [Related]
5. Tamoxifen resistance alters sensitivity to 5-fluorouracil in a subset of estrogen receptor-positive breast cancer.
Watanabe T; Oba T; Tanimoto K; Shibata T; Kamijo S; Ito KI
PLoS One; 2021; 16(6):e0252822. PubMed ID: 34101751
[TBL] [Abstract][Full Text] [Related]
6. Overexpression of the RNA binding protein HuR impairs tumor growth in triple negative breast cancer associated with deficient angiogenesis.
Gubin MM; Calaluce R; Davis JW; Magee JD; Strouse CS; Shaw DP; Ma L; Brown A; Hoffman T; Rold TL; Atasoy U
Cell Cycle; 2010 Aug; 9(16):3337-46. PubMed ID: 20724828
[TBL] [Abstract][Full Text] [Related]
7. Global characterization of signalling networks associated with tamoxifen resistance in breast cancer.
Browne BC; Hochgräfe F; Wu J; Millar EK; Barraclough J; Stone A; McCloy RA; Lee CS; Roberts C; Ali NA; Boulghourjian A; Schmich F; Linding R; Farrow L; Gee JM; Nicholson RI; O'Toole SA; Sutherland RL; Musgrove EA; Butt AJ; Daly RJ
FEBS J; 2013 Nov; 280(21):5237-57. PubMed ID: 23876235
[TBL] [Abstract][Full Text] [Related]
8. Polyamines regulate the stability of activating transcription factor-2 mRNA through RNA-binding protein HuR in intestinal epithelial cells.
Xiao L; Rao JN; Zou T; Liu L; Marasa BS; Chen J; Turner DJ; Zhou H; Gorospe M; Wang JY
Mol Biol Cell; 2007 Nov; 18(11):4579-90. PubMed ID: 17804813
[TBL] [Abstract][Full Text] [Related]
9. Tamoxifen through GPER upregulates aromatase expression: a novel mechanism sustaining tamoxifen-resistant breast cancer cell growth.
Catalano S; Giordano C; Panza S; Chemi F; Bonofiglio D; Lanzino M; Rizza P; Romeo F; Fuqua SA; Maggiolini M; Andò S; Barone I
Breast Cancer Res Treat; 2014 Jul; 146(2):273-85. PubMed ID: 24928526
[TBL] [Abstract][Full Text] [Related]
10. Characterization of new estrogen receptor destabilizing compounds: effects on estrogen-sensitive and tamoxifen-resistant breast cancer.
Hoffmann J; Bohlmann R; Heinrich N; Hofmeister H; Kroll J; Künzer H; Lichtner RB; Nishino Y; Parczyk K; Sauer G; Gieschen H; Ulbrich HF; Schneider MR
J Natl Cancer Inst; 2004 Feb; 96(3):210-8. PubMed ID: 14759988
[TBL] [Abstract][Full Text] [Related]
11. Endocrine resistance associated with activated ErbB system in breast cancer cells is reversed by inhibiting MAPK or PI3K/Akt signaling pathways.
Ghayad SE; Vendrell JA; Ben Larbi S; Dumontet C; Bieche I; Cohen PA
Int J Cancer; 2010 Jan; 126(2):545-62. PubMed ID: 19609946
[TBL] [Abstract][Full Text] [Related]
12. Acquisition of epithelial-mesenchymal transition phenotype in the tamoxifen-resistant breast cancer cell: a new role for G protein-coupled estrogen receptor in mediating tamoxifen resistance through cancer-associated fibroblast-derived fibronectin and β1-integrin signaling pathway in tumor cells.
Yuan J; Liu M; Yang L; Tu G; Zhu Q; Chen M; Cheng H; Luo H; Fu W; Li Z; Yang G
Breast Cancer Res; 2015 May; 17(1):69. PubMed ID: 25990368
[TBL] [Abstract][Full Text] [Related]
13. The Wilms' tumor suppressor WT1 regulates expression of members of the epidermal growth factor receptor (EGFR) and estrogen receptor in acquired tamoxifen resistance.
Wang L; Zhang X; Wang ZY
Anticancer Res; 2010 Sep; 30(9):3637-42. PubMed ID: 20944147
[TBL] [Abstract][Full Text] [Related]
14. Role of RNA binding protein HuR in ductal carcinoma in situ of the breast.
Heinonen M; Hemmes A; Salmenkivi K; Abdelmohsen K; Vilén ST; Laakso M; Leidenius M; Salo T; Hautaniemi S; Gorospe M; Heikkilä P; Haglund C; Ristimäki A
J Pathol; 2011 Aug; 224(4):529-39. PubMed ID: 21480233
[TBL] [Abstract][Full Text] [Related]
15. Tamoxifen overcomes the trastuzumab-resistance of SK-BR-3 tumorspheres by targeting crosstalk between cytoplasmic estrogen receptor α and the EGFR/HER2 signaling pathway.
Kwon YS; Nam KS; Kim S
Biochem Pharmacol; 2021 Aug; 190():114635. PubMed ID: 34058187
[TBL] [Abstract][Full Text] [Related]
16. HuR, a key post-transcriptional regulator, and its implication in progression of breast cancer.
Yuan Z; Sanders AJ; Ye L; Jiang WG
Histol Histopathol; 2010 Oct; 25(10):1331-40. PubMed ID: 20712017
[TBL] [Abstract][Full Text] [Related]
17. Expression of vascular endothelial growth factor-A and mRNA stability factor HuR in human astrocytic tumors.
Ido K; Nakagawa T; Sakuma T; Takeuchi H; Sato K; Kubota T
Neuropathology; 2008 Dec; 28(6):604-11. PubMed ID: 18498284
[TBL] [Abstract][Full Text] [Related]
18. HuR contributes to cyclin E1 deregulation in MCF-7 breast cancer cells.
Guo X; Hartley RS
Cancer Res; 2006 Aug; 66(16):7948-56. PubMed ID: 16912169
[TBL] [Abstract][Full Text] [Related]
19. The RNA-binding protein HuR regulates GATA3 mRNA stability in human breast cancer cell lines.
Licata LA; Hostetter CL; Crismale J; Sheth A; Keen JC
Breast Cancer Res Treat; 2010 Jul; 122(1):55-63. PubMed ID: 19728080
[TBL] [Abstract][Full Text] [Related]
20. Human epidermal growth factor receptor 2 status modulates subcellular localization of and interaction with estrogen receptor alpha in breast cancer cells.
Yang Z; Barnes CJ; Kumar R
Clin Cancer Res; 2004 Jun; 10(11):3621-8. PubMed ID: 15173068
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
